Charles Schwab Investment Management Inc Mirum Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 332,639 shares of MIRM stock, worth $16.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

332,639

Previous 328,161 1.36%

Holding current value

$16.8 Million

Previous $12.8 Million 7.47%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$37.85 - $46.65 $169,492 - $208,898	4,478 Added 1.36%	332,639 $13.8 Million
Q3 2024 Nov 12, 2024	BUY	$33.68 - $44.74 $577,578 - $767,246	17,149 Added 5.51%	328,161 $12.8 Million
Q2 2024 Aug 12, 2024	BUY	$23.57 - $34.85 $927,668 - $1.37 Million	39,358 Added 14.49%	311,012 $10.6 Million
Q1 2024 May 08, 2024	BUY	$24.92 - $30.02 $123,927 - $149,289	4,973 Added 1.86%	271,654 $6.82 Million
Q4 2023 Feb 06, 2024	BUY	$27.14 - $34.93 $1.14 Million - $1.47 Million	42,110 Added 18.75%	266,681 $7.87 Million
Q3 2023 Nov 08, 2023	BUY	$24.63 - $32.85 $3.75 Million - $5 Million	152,287 Added 210.68%	224,571 $7.1 Million
Q2 2023 Aug 09, 2023	BUY	$23.51 - $30.09 $459,502 - $588,109	19,545 Added 37.06%	72,284 $1.87 Million
Q1 2023 May 11, 2023	BUY	$19.19 - $24.1 $18,345 - $23,039	956 Added 1.85%	52,739 $1.27 Million
Q4 2022 Feb 13, 2023	BUY	$17.59 - $23.83 $25,153 - $34,076	1,430 Added 2.84%	51,783 $1.01 Million
Q3 2022 Nov 14, 2022	BUY	$19.98 - $29.44 $156,683 - $230,868	7,842 Added 18.45%	50,353 $1.06 Million
Q2 2022 Aug 15, 2022	BUY	$18.42 - $27.5 $497,542 - $742,802	27,011 Added 174.26%	42,511 $828,000
Q1 2022 May 13, 2022	BUY	$15.5 - $23.93 $12,462 - $19,239	804 Added 5.47%	15,500 $342,000
Q3 2021 Nov 16, 2021	SELL	$13.95 - $20.18 $847,071 - $1.23 Million	-60,722 Reduced 80.51%	14,696 $293,000
Q2 2021 Aug 16, 2021	SELL	$15.84 - $20.6 $14,240 - $18,519	-899 Reduced 1.18%	75,418 $1.3 Million
Q1 2021 May 17, 2021	BUY	$16.29 - $21.92 $273,085 - $367,466	16,764 Added 28.15%	76,317 $1.51 Million
Q4 2020 Feb 16, 2021	BUY	$15.75 - $25.45 $16,789 - $27,129	1,066 Added 1.82%	59,553 $1.04 Million
Q3 2020 Nov 13, 2020	BUY	$18.4 - $26.59 $794,033 - $1.15 Million	43,154 Added 281.45%	58,487 $1.13 Million
Q2 2020 Aug 14, 2020	BUY	$11.51 - $20.97 $48,975 - $89,227	4,255 Added 38.41%	15,333 $299,000
Q1 2020 May 15, 2020	BUY	$9.38 - $23.79 $103,911 - $263,545	11,078 New	11,078 $156,000

Others Institutions Holding MIRM

# of Institutions

197

Shares Held

54.3M

Call Options Held

177K

Put Options Held

167K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.85B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Mirum Pharmaceuticals, Inc. Transaction History